Skip to main content
. 2014 Oct 2;39(2):142–149. doi: 10.1111/aor.12345

Table 1.

Patient and treatment characteristics of 366 chronic HDF patients

Mean ± SD or %
Male (%) 58.2
Age (years) 65.8 ± 14.4
Dry body weight (kg) 67.8 ± 14.8
Primary renal disease Glomerulonephritis 8.9
Diabetic nephropathy 14.7
Cystic kidney disease 3.6
Chronic pyelonephritis 6.6
Vascular disease/hypertension 34.3
Unknown/other 31.8
Comorbidities Diabetes mellitus 22.7
Coronary artery disease 4.2
Congestive heart failure 13.9
Peripheral vascular disease 13.6
Cerebrovascular disease 13.9
Chronic pulmonary disease 8.3
Tumor 5.8
Time on renal replacement therapy (years) 6.5 ± 6.1
Vascular access Arteriovenous fistula 63.7
Graft 21.9
Central venous catheter 14.4
Hemoglobin (g/L) 11.2 ± 1.3
Hematocrit (%) 33.8 ± 3.9
Serum albumin (g/dL) 4.04 ± 0.42
Effective treatment time delivered (min) 243.4 ± 14.2
Mean blood flow rate delivered (mL/min) 401.2 ± 53.7
Intradialytic weight loss (L/treatment) 2.43 ± 0.70
Kt/V 1.90 ± 0.41
Substitution volume (L/treatment) 23.53 ± 3.37
Convection volume (L/treatment) 25.95 ± 3.33
Convection flow rate (mL/min) 106.6 ± 11.6
Filtration fraction (%) 26.9 ± 3.0